Annual ROA
-103.31%
-63.71%-160.88%
30 September 2022
Summary:
NeuBase Therapeutics annual return on assets is currently -103.31%, with the most recent change of -63.71% (-160.88%) on 30 September 2022. During the last 3 years, it has fallen by -63.71% (-160.88%).NBSE ROA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly ROA
-62.41%
+14.17%+18.50%
30 September 2023
Summary:
NeuBase Therapeutics quarterly return on assets is currently -62.41%, with the most recent change of +14.17% (+18.50%) on 30 September 2023.NBSE Quarterly ROA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
NBSE ROA Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | - | - |
| 3 y3 years | -160.9% | -17.7% |
| 5 y5 years | +50.5% | +75.2% |
NBSE ROA High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | ||||
| 5 y | 5 years | ||||
| alltime | all time | -395.1% | -290.4% |
NeuBase Therapeutics ROA History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2023 | - | -62.41%(-18.5%) |
| June 2023 | - | -76.58%(-6.8%) |
| Mar 2023 | - | -82.14%(-0.7%) |
| Dec 2022 | - | -82.72%(+9.3%) |
| Sept 2022 | -103.31%(+160.9%) | -75.67%(+19.3%) |
| June 2022 | - | -63.43%(+13.4%) |
| Mar 2022 | - | -55.94%(+4.9%) |
| Dec 2021 | - | -53.34%(+0.6%) |
| Sept 2021 | -39.60%(-21.5%) | -53.01%(-6.5%) |
| June 2021 | - | -56.67%(+2.5%) |
| Mar 2021 | - | -55.30%(-9.4%) |
| Dec 2020 | - | -61.02%(-20.9%) |
| Sept 2020 | -50.47%(-75.8%) | -77.10%(-63.1%) |
| June 2020 | - | -208.80%(-38.6%) |
| Mar 2020 | - | -339.79%(+16.4%) |
| Dec 2019 | - | -292.04%(+16.0%) |
| Sept 2019 | -208.53%(-96.1%) | -251.69%(+93.1%) |
| June 2019 | - | -130.32%(+40.7%) |
| Mar 2019 | - | -92.59%(+12.2%) |
| Dec 2018 | - | -82.53%(-4.7%) |
| Sept 2018 | -5303.25%(+6120.1%) | -86.60%(+58.6%) |
| June 2018 | - | -54.61%(-7.9%) |
| Mar 2018 | - | -59.28%(-21.8%) |
| Dec 2017 | - | -75.80%(-6.9%) |
| Sept 2017 | -85.26%(-2.6%) | -81.38%(-4.3%) |
| June 2017 | - | -85.03%(-12.7%) |
| Mar 2017 | - | -97.36%(+21.3%) |
| Dec 2016 | - | -80.24%(+14.4%) |
| Sept 2016 | -87.51%(+167.0%) | -70.11%(+24.7%) |
| June 2016 | - | -56.22%(+34.6%) |
| Mar 2016 | - | -41.77%(+18.9%) |
| Dec 2015 | - | -35.13%(+1.6%) |
| Sept 2015 | -32.77%(+14.9%) | -34.57%(-2.9%) |
| June 2015 | - | -35.60%(+0.5%) |
| Mar 2015 | - | -35.42%(-23.4%) |
| Dec 2014 | - | -46.27%(-3.2%) |
| Sept 2014 | -28.51%(-71.0%) | -47.80%(-23.6%) |
| June 2014 | - | -62.59%(-53.0%) |
| Mar 2014 | - | -133.08%(+20.7%) |
| Dec 2013 | - | -110.27%(-11.6%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2013 | -98.41%(+137.9%) | -124.73%(+31.1%) |
| June 2013 | - | -95.13%(-4.7%) |
| Mar 2013 | - | -99.83%(-32.0%) |
| Dec 2012 | - | -146.79%(+155.1%) |
| Sept 2012 | -41.36%(-88.5%) | -57.54%(-60.0%) |
| June 2012 | - | -143.84%(-54.3%) |
| Mar 2012 | - | -314.61%(+29.1%) |
| Dec 2011 | - | -243.65%(-21.4%) |
| Sept 2011 | -361.09%(-1131.4%) | -309.92%(+85.4%) |
| June 2011 | - | -167.19%(-1387.1%) |
| Mar 2011 | - | 12.99%(-5.5%) |
| Dec 2010 | - | 13.75%(-58.0%) |
| Sept 2010 | 35.01%(-149.8%) | 32.77%(-176.9%) |
| June 2010 | - | -42.64%(-10.3%) |
| Mar 2010 | - | -47.56%(-41.6%) |
| Dec 2009 | - | -81.42%(-19.9%) |
| Sept 2009 | -70.24%(-612.0%) | -101.69%(-41.4%) |
| June 2009 | - | -173.44%(-30.8%) |
| Mar 2009 | - | -250.49%(+30.2%) |
| Dec 2008 | - | -192.46%(-3056.4%) |
| Sept 2008 | 13.72%(-101.5%) | 6.51%(-70.8%) |
| June 2008 | - | 22.29%(-105.0%) |
| Mar 2008 | - | -445.92%(+83.8%) |
| Dec 2007 | - | -242.65%(-12.8%) |
| Sept 2007 | -898.01%(-5559.0%) | -278.34%(-0.4%) |
| June 2007 | - | -279.59%(+187.6%) |
| Mar 2007 | - | -97.21%(-1550.9%) |
| Dec 2006 | 16.45%(+286.2%) | 6.70%(-13.4%) |
| Sept 2006 | - | 7.74%(-35.0%) |
| June 2006 | - | 11.90%(+176.7%) |
| Mar 2006 | - | 4.30%(-18.7%) |
| Dec 2005 | 4.26%(-49.2%) | 5.29%(+156.8%) |
| Sept 2005 | - | 2.06%(+524.2%) |
| June 2005 | - | 0.33%(-95.7%) |
| Mar 2005 | - | 7.60%(-5.9%) |
| Dec 2004 | 8.39%(+7.0%) | 8.08%(-39.5%) |
| Sept 2004 | - | 13.35%(+26.1%) |
| June 2004 | - | 10.59%(+133.3%) |
| Mar 2004 | - | 4.54% |
| Dec 2003 | 7.84% | - |
FAQ
- What is NeuBase Therapeutics annual return on assets?
- What is the all time high annual ROA for NeuBase Therapeutics?
- What is NeuBase Therapeutics quarterly return on assets?
- What is the all time high quarterly ROA for NeuBase Therapeutics?
What is NeuBase Therapeutics annual return on assets?
The current annual ROA of NBSE is -103.31%
What is the all time high annual ROA for NeuBase Therapeutics?
NeuBase Therapeutics all-time high annual return on assets is 35.01%
What is NeuBase Therapeutics quarterly return on assets?
The current quarterly ROA of NBSE is -62.41%
What is the all time high quarterly ROA for NeuBase Therapeutics?
NeuBase Therapeutics all-time high quarterly return on assets is 32.77%